Drug developer Barr Pharmaceuticals Inc. said Thursday its subsidiary launched a generic version of the company’s birth control pill, Seasonale.

Barr Laboratories Inc. will market the generic version of the extended cycle oral contraceptive under the name Jolessa. The move is a response to the Food and Drug Administration’s approval of rival Watson Pharmaceuticals Inc.’s generic version of Seasonale. It received approval Tuesday.